Local IL-10 delivery modulates the immune response and enhances repair of volumetric muscle loss muscle injury.

Although quantitative assessment of eMHC + de-novo myofiber count differences between IL-10 treatment (554 ± 116 cells/mm 2 ) and PBS controls (352 ± 141 cells/mm 2 ) showed some elevation in the IL-10 treatment groups, the difference approached (p = 0.058) but did not reach statistical significance (Fig. 5 a,d).

also in 111,027 other papers